Comparative Prevalence Studies of Hepatitis C Patients in Developing Vs Developed Countries

Authors

  • Umer Tahir Faculty of Pharmacy The University of Lahore
  • Qurat ul Ain Faculty of Pharmacy The University of Lahore
  • Rai Waqas Lahore College of Pharmaceutical Sciences Lahore
  • Irfan Bashir Faculty of Pharmacy University of Central Punjab Lahore

DOI:

https://doi.org/10.3329/icpj.v5i12.30412

Keywords:

Viral, Transmissible, Fatal, Mortality, Morbidity, Vaccination, Community

Abstract

Viral hepatitis is one of the common transmissible causes of chronic liver responsible for increased risk of mortality and morbidity. Hepatitis C disease has worldwide high prevalence which is more fatal because of lack of vaccination availability. Present study was conducted with the aim of to address the comparative prevalence and risk factor of hepatitis C. Secondary objective was to evaluate the prevalence of this disease in Pakistan as compared to other countries. Most of the countries in the world do not have significant studies of population infected with Hepatitis C virus (HCV). During 1990-2016, 232 studies were included; containing 117 countries representing that 90% of the world population have 2.3% prevalence. According to studies, developed countries have low HCV prevalence while developing countries have high prevalence. Pakistan being a developing country has second highest HCV prevalence ranging from 4.5 to 8%. The reason of this high prevalence is unawareness about Hepatitis C in community and lack of successful therapies for patients with HCV. In past, developed countries had high prevalence but now they have low incidence because of proper system and awareness. Pakistan needs such kind of public awareness programs and better treatment facilities at affordable price to community.

Tahir et al., International Current Pharmaceutical Journal, November 2016, 5(12): 106-110

http://www.icpjonline.com/documents/Vol5Issue12/02.pdf

Downloads

Download data is not yet available.
Abstract
17
PDF
20

Downloads

Published

2016-11-18

How to Cite

Tahir, U., Ain, Q. ul, Waqas, R., & Bashir, I. (2016). Comparative Prevalence Studies of Hepatitis C Patients in Developing Vs Developed Countries. International Current Pharmaceutical Journal, 5(12), 106–110. https://doi.org/10.3329/icpj.v5i12.30412

Issue

Vol. 5 No. 12 (2016)

Section

Review Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).